Advancing a CRISPR program becomes more complex at every stage.

As manufacturing requirements evolve from IND-enabling studies to clinical development and commercial readiness, choosing the right manufacturing partner becomes increasingly important.

This flyer provides an overview of Synthego's clinical CRISPR manufacturing portfolio, including guide RNA and GMP CRISPR editor manufacturing, as well as stability, analytical, and regulatory services that help keep programs moving forward.